Search

everythinglearnresearchcommunity

for

Search:↓

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Metformin may lower PSA levels, possibly affecting prostate cancer development.

Antiandrogens may help treat conditions like excessive hair growth, prostate tumors, male baldness, and acne by blocking male hormone effects.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Analog 23 is a promising compound for prostate cancer treatment.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Researchers found 63 genes linked to male-pattern baldness, which could help in understanding its biology and developing new treatments.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

New compounds were made that are promising for prostate cancer therapy.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Men who start losing hair at 20 may have a higher chance of getting prostate cancer later.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

Heavy metals like arsenic, cadmium, and lead can increase cancer risk and worsen outcomes.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

The meeting highlighted promising genetic treatments for male fertility issues but noted concerns about certain cancer risks and ICSI safety.